FATE1
gene geneOn this page
Also known as FATECT43
Summary
FATE1 (fetal and adult testis expressed 1, HGNC:24683) is a protein-coding gene on chromosome Xq28, encoding Fetal and adult testis-expressed transcript protein (Q969F0). Involved in the regulation of endoplasmic reticulum (ER)-mitochondria coupling.
This gene encodes a cancer-testis antigen that is highly expressed in hepatocellular carcinomas and other tumors and weakly expressed in normal tissues except testis. The protein is strongly expressed in spermatogonia, primary spermatocytes, and Sertoli cells in seminiferous tubules. This protein may have a role in the control of early testicular differentiation and cell proliferation.
Source: NCBI Gene 89885 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 51 total
- GTEx eGene: eQTL in 12 tissues, sQTL in 1 (q < 0.05)
- MANE Select transcript:
NM_033085 - Notable: 51 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24683 |
| Approved symbol | FATE1 |
| Name | fetal and adult testis expressed 1 |
| Location | Xq28 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FATE, CT43 |
| Ensembl gene | ENSG00000147378 |
| Ensembl biotype | protein_coding |
| OMIM | 300450 |
| Entrez | 89885 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 7 protein_coding
MANE Select: ENST00000370350
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 3: 1
ENST00000370350, ENST00000417321, ENST00000940339, ENST00000940340, ENST00001095947, ENST00001095948, ENST00001134540
RefSeq mRNA: 1 — MANE Select: NM_033085
NM_033085
CCDS: CCDS14700
Canonical transcript exons
ENST00000370350 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000979764 | 151717272 | 151717399 |
| ENSE00000979765 | 151721395 | 151721501 |
| ENSE00000979767 | 151722628 | 151723194 |
| ENSE00001834754 | 151716035 | 151716225 |
| ENSE00003462397 | 151721903 | 151721981 |
Expression profiles
Bgee: expression breadth ubiquitous, 130 present calls, max score 99.25.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2850 / max 239.0750, expressed in 5 samples.
Highest expression (Bgee): testis, adult organism, male germ line stem cell (sensu Vertebrata) in testis, pancreatic ductal cell, adrenal tissue.
Genetic regulation across tissues (GTEx eQTL / sQTL)
FATE1 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 12 tissues and its splicing (sQTL) in 1 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
13 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Brain Frontal Cortex BA9 | eqtl | 1.2e-16 | -0.74 | X:151716148:C:T |
| Nerve Tibial | eqtl | 1.4e-12 | +0.36 | X:151705932:G:A |
| Brain Cortex | eqtl | 2.0e-11 | -0.64 | X:151716148:C:T |
| Brain Anterior cingulate cortex BA24 | eqtl | 7.5e-07 | -0.56 | X:151716148:C:T |
| Heart Left Ventricle | eqtl | 9.7e-06 | -0.28 | X:151716148:C:T |
| Adipose Subcutaneous | eqtl | 4.6e-04 | -0.22 | X:151716148:C:T |
| Muscle Skeletal | eqtl | 1.2e-03 | -0.22 | X:151716148:C:T |
| Testis | sqtl | 1.7e-03 | -0.75 | X:151722864:C:T |
| Thyroid | eqtl | 1.8e-03 | -0.24 | X:151716148:C:T |
| Lung | eqtl | 7.4e-03 | -0.17 | X:151706160:C:T |
| Brain Hypothalamus | eqtl | 1.8e-02 | +0.31 | X:151702667:C:T |
| Small Intestine Terminal Ileum | eqtl | 2.2e-02 | +0.32 | X:150761417:G:C |
| Skin Sun Exposed Lower leg | eqtl | 3.9e-02 | -0.27 | X:152028358:G:A |
FANTOM5 promoters
2 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 197994 | 0.2696 | 4 |
| 197995 | 0.0154 | 3 |
Top tissues by expression
showing 100 of 236 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 99.25 | gold quality |
| left testis | UBERON:0004533 | 99.09 | gold quality |
| testis | UBERON:0000473 | 97.79 | gold quality |
| adult organism | UBERON:0007023 | 93.43 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.07 | gold quality |
| pancreatic ductal cell | CL:0002079 | 82.98 | silver quality |
| adrenal tissue | UBERON:0018303 | 74.11 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 71.15 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 68.57 | gold quality |
| apex of heart | UBERON:0002098 | 65.41 | gold quality |
| ileal mucosa | UBERON:0000331 | 64.97 | silver quality |
| deltoid | UBERON:0001476 | 64.63 | silver quality |
| epithelium of nasopharynx | UBERON:0001951 | 64.20 | gold quality |
| myocardium | UBERON:0002349 | 62.18 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 61.21 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 61.07 | gold quality |
| biceps brachii | UBERON:0001507 | 61.02 | gold quality |
| quadriceps femoris | UBERON:0001377 | 60.69 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 59.46 | gold quality |
| oral cavity | UBERON:0000167 | 59.44 | gold quality |
| parotid gland | UBERON:0001831 | 59.42 | gold quality |
| vastus lateralis | UBERON:0001379 | 59.37 | gold quality |
| skin of hip | UBERON:0001554 | 58.50 | silver quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 58.16 | gold quality |
| gingival epithelium | UBERON:0001949 | 57.70 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 57.20 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 56.72 | silver quality |
| medial globus pallidus | UBERON:0002477 | 56.60 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 56.40 | gold quality |
| decidua | UBERON:0002450 | 55.87 | gold quality |
| heart right ventricle | UBERON:0002080 | 55.78 | gold quality |
| muscle tissue | UBERON:0002385 | 55.35 | silver quality |
| kidney epithelium | UBERON:0004819 | 55.32 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 55.14 | gold quality |
| duodenum | UBERON:0002114 | 55.03 | gold quality |
| globus pallidus | UBERON:0001875 | 54.92 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 54.89 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 54.66 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| cartilage tissue | UBERON:0002418 | 53.49 | gold quality |
| upper leg skin | UBERON:0004262 | 53.24 | silver quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 52.97 | gold quality |
| metanephros | UBERON:0000081 | 52.85 | gold quality |
| visceral pleura | UBERON:0002401 | 52.63 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 52.46 | gold quality |
| jejunal mucosa | UBERON:0000399 | 52.18 | gold quality |
| parietal pleura | UBERON:0002400 | 51.84 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 51.81 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 51.76 | gold quality |
| cauda epididymis | UBERON:0004360 | 51.47 | gold quality |
| cardiac ventricle | UBERON:0002082 | 51.42 | gold quality |
| heart left ventricle | UBERON:0002084 | 51.40 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 51.31 | gold quality |
| prefrontal cortex | UBERON:0000451 | 51.02 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 50.97 | gold quality |
| seminal vesicle | UBERON:0000998 | 50.55 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 50.37 | gold quality |
| right frontal lobe | UBERON:0002810 | 50.22 | gold quality |
| corpus epididymis | UBERON:0004359 | 50.06 | gold quality |
| neocortex | UBERON:0001950 | 50.04 | gold quality |
| jejunum | UBERON:0002115 | 49.67 | gold quality |
| amniotic fluid | UBERON:0000173 | 49.61 | gold quality |
| caput epididymis | UBERON:0004358 | 49.58 | gold quality |
| frontal cortex | UBERON:0001870 | 49.47 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 49.31 | gold quality |
| cerebellar vermis | UBERON:0004720 | 48.63 | gold quality |
| buccal mucosa cell | CL:0002336 | 48.33 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 48.31 | gold quality |
| muscle of leg | UBERON:0001383 | 48.04 | gold quality |
| cerebral cortex | UBERON:0000956 | 47.89 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 47.63 | gold quality |
| thyroid gland | UBERON:0002046 | 47.54 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 47.40 | gold quality |
| gastrocnemius | UBERON:0001388 | 47.31 | gold quality |
| right coronary artery | UBERON:0001625 | 46.83 | gold quality |
| heart | UBERON:0000948 | 46.80 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 46.67 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 46.61 | gold quality |
| penis | UBERON:0000989 | 46.53 | gold quality |
| oocyte | CL:0000023 | 46.44 | gold quality |
| pituitary gland | UBERON:0000007 | 46.21 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 46.21 | silver quality |
| mammary gland | UBERON:0001911 | 46.11 | silver quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 46.10 | gold quality |
| ectocervix | UBERON:0012249 | 45.90 | gold quality |
| thymus | UBERON:0002370 | 45.88 | silver quality |
| cortex of kidney | UBERON:0001225 | 45.84 | gold quality |
| right adrenal gland | UBERON:0001233 | 45.69 | gold quality |
| entorhinal cortex | UBERON:0002728 | 45.60 | gold quality |
| kidney | UBERON:0002113 | 45.24 | gold quality |
| metanephros cortex | UBERON:0010533 | 45.01 | gold quality |
| placenta | UBERON:0001987 | 44.67 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 44.51 | gold quality |
| adrenal gland | UBERON:0002369 | 44.32 | gold quality |
| synovial joint | UBERON:0002217 | 44.26 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 44.24 | gold quality |
| adipose tissue | UBERON:0001013 | 43.44 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 43.24 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 3978.63 |
| E-GEOD-124263 | yes | 843.59 |
| E-ANND-3 | no | 1.63 |
HPA expression
RNA tissue specificity: Tissue enriched
28 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Testis | tissue | 151.7 | medium |
| Thymus | tissue | 2.1 | |
| Postcentral gyrus | tissue | 0.8 | |
| Pituitary gland | tissue | 0.5 | |
| Skeletal muscle | tissue | 0.5 | not detected |
| Heart muscle | tissue | 0.3 | not detected |
| Ovary | tissue | 0.3 | not detected |
| Adipose tissue | tissue | 0.3 | not detected |
| Tongue | tissue | 0.3 | |
| Small intestine | tissue | 0.3 | not detected |
| Stomach 1 | tissue | 0.2 | not detected |
| Vagina | tissue | 0.2 | not detected |
| Thyroid gland | tissue | 0.2 | not detected |
| Lung | tissue | 0.2 | not detected |
| Duodenum | tissue | 0.2 | not detected |
| Lymph node | tissue | 0.1 | not detected |
| Rectum | tissue | 0.1 | not detected |
| Parathyroid gland | tissue | 0.1 | not detected |
| Urinary bladder | tissue | 0.1 | not detected |
| Endometrium 1 | tissue | 0.1 | not detected |
| Spleen | tissue | 0.1 | not detected |
| Gallbladder | tissue | 0.1 | not detected |
| Kidney | tissue | 0.1 | not detected |
| Spinal cord | tissue | 0.1 | |
| Hippocampus | tissue | 0.1 | not detected |
| Tonsil | tissue | 0.1 | not detected |
| Caudate putamen | tissue | 0.1 | |
| Appendix | tissue | 0.1 | not detected |
Brain sub-regions (HPA Brain Atlas): detected in 76; highest nTPM — Area parastriata, superior (1.0), Middle temporal gyrus (0.8), Postcentral gyrus, middle (0.8), Superior temporal gyrus (0.8), Angular gyrus (0.7).
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): DNMT3A, NR5A1, STAT4
miRNA regulators (miRDB)
Targeting FATE1 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
21 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-1321 | 99.84 | 65.30 | 1811 |
| HSA-MIR-4756-5P | 99.84 | 64.98 | 1809 |
| HSA-MIR-4739 | 99.84 | 65.25 | 1832 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-671-5P | 99.52 | 67.11 | 1277 |
| HSA-MIR-889-5P | 99.41 | 68.75 | 1025 |
| HSA-MIR-6828-5P | 99.31 | 69.21 | 1433 |
| HSA-MIR-4721 | 99.26 | 66.05 | 818 |
| HSA-MIR-6852-5P | 99.17 | 66.69 | 2073 |
| HSA-MIR-3125 | 99.14 | 68.49 | 2269 |
| HSA-MIR-3916 | 98.99 | 68.04 | 2155 |
| HSA-MIR-6859-5P | 98.99 | 68.07 | 2049 |
| HSA-MIR-3154 | 98.94 | 66.55 | 1455 |
| HSA-MIR-219A-1-3P | 98.91 | 67.87 | 639 |
| HSA-MIR-583 | 98.71 | 67.44 | 1791 |
| HSA-MIR-4700-5P | 98.63 | 67.43 | 1915 |
| HSA-MIR-3179 | 98.22 | 65.90 | 1445 |
| HSA-MIR-3192-5P | 96.98 | 65.76 | 1926 |
| HSA-MIR-656-5P | 96.82 | 67.67 | 372 |
Functional genomics
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000370350 — one region, missense o/e 1.11.
Literature-anchored findings (GeneRIF, showing 4)
- This study has shown that only 1.4% of infertile men have mutations in the FATE gene, and that some of these mutations do not singly cause infertility. (PMID:12811541)
- FATE1 is a key survival factor in multiple oncogenic backgrounds. FATE1 prevents the accumulation of the stress-sensing BH3-only protein, BCL-2-Interacting Killer (BIK), thereby permitting viability in the presence of toxic stimuli. (PMID:26567849)
- In patients with ACC, FATE1 expression in their tumor is inversely correlated with their overall survival. the ER-mitochondria uncoupling activity of FATE1 is harnessed by cancer cells to escape apoptotic death and resist the action of chemotherapeutic drugs. (PMID:27402544)
- Study reports that EWSR1-FLI1 directly activates the anomalous expression of FATE1 in Ewing sarcoma. FATE1 is essential for Ewing sarcoma survival through the destabilization of BNIP3L, a poorly characterized BH3-only protein that is toxic to Ewing sarcoma cells. (PMID:31036566)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Fate1 | ENSMUSG00000053593 |
| rattus_norvegicus | ENSRNOG00000066670 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Bos taurus | Q3ZCD8 | 93.6% | Diamond |
| Sus scrofa | Q95LB4 | 67.1% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| CNGA2 | protein-coding | 1260 |
| GABRE | protein-coding | 2564 |
| MIR224 | ncRNA | 407009 |
| MAGEA4 | protein-coding | 4103 |
| MAGEA4-AS1 | ncRNA | 105373368 |
| PRRG3 | protein-coding | 79057 |
| PASD1 | protein-coding | 139135 |
| VMA21 | protein-coding | 203547 |
Protein
Protein identifiers
Fetal and adult testis-expressed transcript protein — Q969F0 (reviewed: Q969F0)
Alternative names: Cancer/testis antigen 43, Tumor antigen BJ-HCC-2
All UniProt accessions (2): Q969F0, H7C1I5
UniProt curated annotations — full annotation on UniProt →
Function. Involved in the regulation of endoplasmic reticulum (ER)-mitochondria coupling. Negatively regulates the ER-mitochondria distance and Ca(2+) transfer from ER to mitochondria possibly implicating it in the regulation of apoptosis. May collaborate with RNF183 to restrain BIK protein levels thus regulating apoptotic signaling.
Subunit / interactions. Interacts with BIK and RNF183. Interacts with IMMT/MIC60and EMD.
Subcellular location. Mitochondrion. Mitochondrion outer membrane. Endoplasmic reticulum membrane.
Tissue specificity. Testis-specific in fetus (aged from 6 to 11 weeks). In adult, expressed predominantly in testis, with some expression in lung, heart, kidney, adrenal gland and whole brain. Highly expressed in certain types of cancer tissues such as hepatocellular carcinoma, colon and gastric cancer. Weakly expressed in normal pancreas.
RefSeq proteins (1): NP_149076* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR039153 | FATE1 | Family |
| IPR039433 | Mff-like_dom | Domain |
Pfam: PF05644
UniProt features (7 total): sequence variant 3, chain 1, transmembrane region 1, region of interest 1, mutagenesis site 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q969F0-F1 | 64.37 | 0.18 |
Human Protein Atlas
Protein class: Predicted membrane proteins, Predicted intracellular proteins
Protein evidence: Evidence at protein level
Antibody reliability (HPA): IH enhanced
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (1)
| Position | Phenotype |
|---|---|
| 151 | impairs association with mitochondria. |
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 26 (showing top):
GOBP_MITOCHONDRIAL_CALCIUM_ION_HOMEOSTASIS, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_MONOATOMIC_ION_HOMEOSTASIS, GOCC_ORGANELLE_MEMBRANE_CONTACT_SITE, GOBP_HOMEOSTATIC_PROCESS, GOBP_CHEMICAL_HOMEOSTASIS, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOCC_ORGANELLE_SUBCOMPARTMENT, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_BINDING, GOCC_ORGANELLE_ENVELOPE, chrXq28, GOCC_MITOCHONDRIA_ASSOCIATED_ENDOPLASMIC_RETICULUM_MEMBRANE_CONTACT_SITE, GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP, GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_UP
GO Biological Process (4): apoptotic process (GO:0006915), negative regulation of apoptotic process (GO:0043066), negative regulation of mitochondrial calcium ion concentration (GO:0051562), regulation of apoptotic process (GO:0042981)
GO Molecular Function (3): ubiquitin protein ligase binding (GO:0031625), identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (6): mitochondrial outer membrane (GO:0005741), endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), mitochondria-associated endoplasmic reticulum membrane contact site (GO:0044233), cytoplasm (GO:0005737), mitochondrion (GO:0005739)
GO top-level categories
22 GO namespaces:
| Category | Terms |
|---|---|
| apoptotic process | 2 |
| cytoplasm | 2 |
| intracellular membrane-bounded organelle | 2 |
| programmed cell death | 1 |
| apoptotic signaling pathway | 1 |
| execution phase of apoptosis | 1 |
| regulation of apoptotic process | 1 |
| negative regulation of programmed cell death | 1 |
| mitochondrial calcium ion homeostasis | 1 |
| regulation of programmed cell death | 1 |
| ubiquitin-like protein ligase binding | 1 |
| protein binding | 1 |
| binding | 1 |
| mitochondrial membrane | 1 |
| organelle outer membrane | 1 |
| endomembrane system | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| organelle membrane contact site | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 7 of 13 annotations. The rest are phylogenetic / computational / electronic (IEA).
7 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| negative regulation of apoptotic process | BP | direct assay |
| negative regulation of mitochondrial calcium ion concentration | BP | direct assay |
| endoplasmic reticulum | CC | direct assay |
| mitochondria-associated endoplasmic reticulum membrane contact site | CC | direct assay |
| mitochondrial outer membrane | CC | direct assay |
| identical protein binding | MF | physical interaction |
| ubiquitin protein ligase binding | MF | direct assay |
Protein interactions and networks
STRING
showing 15 of 484 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FATE1 | TOPAZ1 | Q8N9V7 | 433 |
| FATE1 | RNF183 | Q96D59 | 427 |
| FATE1 | FMR1NB | Q8N0W7 | 419 |
| FATE1 | PROSER2 | Q86WR7 | 402 |
| FATE1 | SPANXC | Q9NY87 | 386 |
| FATE1 | SPANXD | Q9BXN6 | 380 |
| FATE1 | CCDC110 | Q8TBZ0 | 346 |
| FATE1 | CAGE1 | Q8TC20 | 341 |
| FATE1 | YJU2B | P13994 | 339 |
| FATE1 | PACS2 | Q86VP3 | 325 |
| FATE1 | XAGE1B | Q9HD64 | 323 |
| FATE1 | RMDN3 | Q96TC7 | 322 |
| FATE1 | ZNF165 | P49910 | 313 |
| FATE1 | PLAC1 | Q9HBJ0 | 310 |
| FATE1 | TESPA1 | A2RU30 | 308 |
IntAct
Human interaction partners of FATE1 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
showing 30 of 108 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| EMD | physical association | 0.850 | 10 |
| BIK | physical association | 0.830 | 8 |
| CCDC70 | physical association | 0.780 | 7 |
| INPP5K | physical association | 0.780 | 7 |
| NRG4 | physical association | 0.780 | 7 |
| SYNGR1 | physical association | 0.720 | 9 |
| BCL2L2 | physical association | 0.720 | 6 |
| BNIP2 | physical association | 0.720 | 6 |
| BNIP3 | physical association | 0.720 | 6 |
| CD79A | physical association | 0.720 | 6 |
| KASH5 | physical association | 0.720 | 6 |
| KCNS2 | physical association | 0.720 | 6 |
| MARCHF2 | physical association | 0.720 | 6 |
| NDUFB11 | physical association | 0.720 | 6 |
| PRRG2 | physical association | 0.720 | 6 |
| RPRM | physical association | 0.720 | 6 |
| SEC22A | physical association | 0.720 | 6 |
| SEC22C | physical association | 0.720 | 6 |
| SLC38A1 | physical association | 0.720 | 6 |
| SLC7A1 | physical association | 0.720 | 6 |
| SYNDIG1 | physical association | 0.720 | 6 |
| TRAF3IP3 | physical association | 0.720 | 6 |
| USP20 | physical association | 0.720 | 6 |
| YIPF4 | physical association | 0.720 | 6 |
| GPR25 | physical association | 0.700 | 5 |
| MARCHF5 | physical association | 0.670 | 4 |
| RNF183 | physical association | 0.670 | 4 |
| SMIM14 | physical association | 0.670 | 4 |
| TIMMDC1 | physical association | 0.670 | 4 |
| TMEM11 | physical association | 0.670 | 4 |
BioGRID (151 interactions; top human partners by supporting records): EMD (Two-hybrid; 4 records), BIK (Two-hybrid; 3 records), NRG4 (Two-hybrid; 3 records), SYNGR1 (Two-hybrid; 3 records), AGTRAP (Two-hybrid; 2 records), BCL2L2 (Two-hybrid; 2 records), BNIP2 (Two-hybrid; 2 records), BNIP3 (Two-hybrid; 2 records), CCDC155 (Two-hybrid; 2 records), CCDC70 (Two-hybrid; 2 records), CD79A (Two-hybrid; 2 records), GPR25 (Two-hybrid; 2 records), INPP5K (Two-hybrid; 2 records), KCNS2 (Two-hybrid; 2 records), LNPEP (Two-hybrid; 2 records)
Disease & clinical
Genetic variants
Variant evidence for FATE1: 51 ClinVar records (0 pathogenic / likely pathogenic); 1 GWAS association.
ClinVar
51 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 31 |
| Likely benign | 5 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 34 predictions of 475):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| X:151716226–151716227 | donor_loss | 1.0000 | 3 |
| X:151721901–151721902 | acceptor_loss | 1.0000 | 6 |
| X:151721905 | acceptor_gain | 1.0000 | |
| X:151721982–151721983 | donor_loss | 1.0000 | 5 |
| X:151716226 | donor_loss | 0.9900 | |
| X:151717400–151717401 | donor_loss | 0.9900 | 4 |
| X:151721393–151721394 | acceptor_loss | 0.9900 | 5 |
| X:151721394 | acceptor_gain | 0.9900 | |
| X:151721502–151721503 | donor_loss | 0.9900 | 6 |
| X:151722563–151722564 | acceptor_gain | 0.9900 | 2 |
AlphaMissense
104 missense substitutions predicted likely pathogenic (of 1,190 scored), across 45 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| E152 | 6 | 0.765 | 0.890 |
| W178 | 6 | 0.755 | 0.926 |
| E133 | 6 | 0.746 | 0.863 |
| R147 | 4 | 0.750 | 0.896 |
| Q140 | 4 | 0.744 | 0.850 |
| W68 | 4 | 0.725 | 0.770 |
| M134 | 4 | 0.659 | 0.674 |
| S173 | 3 | 0.977 | 0.977 |
| L169 | 3 | 0.797 | 0.870 |
| N176 | 3 | 0.797 | 0.874 |
| F110 | 3 | 0.793 | 0.793 |
| E162 | 3 | 0.740 | 0.827 |
| L177 | 3 | 0.736 | 0.884 |
| L148 | 3 | 0.732 | 0.936 |
| R138 | 3 | 0.718 | 0.755 |
| F105 | 3 | 0.715 | 0.715 |
| M137 | 3 | 0.676 | 0.696 |
| R161 | 3 | 0.675 | 0.723 |
| I165 | 3 | 0.626 | 0.653 |
| A172 | 2 | 0.886 | 0.937 |
HPA cancer prognostics
RNA cancer specificity: Group enriched (Kidney Renal Clear Cell Carcinoma, Testicular Germ Cell Tumor)
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
2 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Kidney Renal Clear Cell Carcinoma (TCGA) | favorable | 1.05e-06 |
| Kidney Renal Clear Cell Carcinoma (validation) | favorable | 0.00013 |
Disease associations
OMIM: gene MIM:300450 | disease phenotypes:
GWAS associations
1 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST008887_8 | Systemising | 1e-6 |
EFO canonical traits (from GWAS)
1 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0010221 | systemising measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sotorasib | affects cotreatment, increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| trametinib | affects cotreatment, increases expression | 1 |
| NVP-BKM120 | affects cotreatment, increases expression | 1 |
| Decitabine | increases expression | 1 |
| Benzo(a)pyrene | increases methylation, affects methylation | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.